ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics

Hiroshi Mitsumoto, Pam Factor-Litvak, Howard Andrews, Raymond R. Goetz, Leslie Andrews, Judith G. Rabkin, Martin Mcelhiney, Jeri Nieves, Regina M. Santella, Jennifer Murphy, Jonathan Hupf, Jess Singleton, David Merle, Mary Kilty, Daragh Heitzman, Richard S. Bedlack, Robert G. Miller, Jonathan S. Katz, Dallas Forshew, Richard J. BarohnEric J. Sorenson, Bjorn Oskarsson, Jose Americo M Fernandes Filho, Edward J. Kasarskis, Catherine Lomen-Hoerth, Tahseen Mozaffar, Yvonne D. Rollins, Sharon P. Nations, Andrea J. Swenson, Jeremy M. Shefner, Jinsy A. Andrews, Boguslawa A. Koczon-Jaremko

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In a multicenter study of newly diagnosed ALS patients without a reported family history of ALS, we are prospectively investigating whether markers of oxidative stress (OS) are associated with disease progression. Methods utilize an extensive structured telephone interview ascertaining environmental, lifestyle, dietary and psychological risk factors associated with OS. Detailed assessments were performed at baseline and at 3-6 month intervals during the ensuing 30 months. Our biorepository includes DNA, plasma, urine, and skin. Three hundred and fifty-five patients were recruited. Subjects were enrolled over a 36-month period at 16 sites. To meet the target number of subjects, the recruitment period was prolonged and additional sites were included. Results showed that demographic and disease characteristics were similar between 477 eligible/non-enrolled and enrolled patients, the only difference being type of health insurance among enrolled patients. Sites were divided into three groups by the number of enrolled subjects. Comparing these three groups, the Columbia site had fewer 'definite ALS' diagnoses. This is the first prospective, interdisciplinary, in-depth, multicenter epidemiological investigation of OS related to ALS progression and has been accomplished by an aggressive recruitment process. The baseline demographic and disease features of the study sample are now fully characterized.

Original languageEnglish (US)
Pages (from-to)192-203
Number of pages12
JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume15
Issue number3-4
DOIs
StatePublished - Jun 2014

Fingerprint

Multicenter Studies
Oxidative Stress
Cohort Studies
Demography
Health Insurance
Disease Progression
Life Style
Urine
Interviews
Psychology
Skin
DNA

Keywords

  • ALS
  • Disease progression
  • Epidemiology
  • Oxidative stress
  • Survival

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS) : Study methodology, recruitment, and baseline demographic and disease characteristics. / Mitsumoto, Hiroshi; Factor-Litvak, Pam; Andrews, Howard; Goetz, Raymond R.; Andrews, Leslie; Rabkin, Judith G.; Mcelhiney, Martin; Nieves, Jeri; Santella, Regina M.; Murphy, Jennifer; Hupf, Jonathan; Singleton, Jess; Merle, David; Kilty, Mary; Heitzman, Daragh; Bedlack, Richard S.; Miller, Robert G.; Katz, Jonathan S.; Forshew, Dallas; Barohn, Richard J.; Sorenson, Eric J.; Oskarsson, Bjorn; Fernandes Filho, Jose Americo M; Kasarskis, Edward J.; Lomen-Hoerth, Catherine; Mozaffar, Tahseen; Rollins, Yvonne D.; Nations, Sharon P.; Swenson, Andrea J.; Shefner, Jeremy M.; Andrews, Jinsy A.; Koczon-Jaremko, Boguslawa A.

In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 15, No. 3-4, 06.2014, p. 192-203.

Research output: Contribution to journalArticle

Mitsumoto, H, Factor-Litvak, P, Andrews, H, Goetz, RR, Andrews, L, Rabkin, JG, Mcelhiney, M, Nieves, J, Santella, RM, Murphy, J, Hupf, J, Singleton, J, Merle, D, Kilty, M, Heitzman, D, Bedlack, RS, Miller, RG, Katz, JS, Forshew, D, Barohn, RJ, Sorenson, EJ, Oskarsson, B, Fernandes Filho, JAM, Kasarskis, EJ, Lomen-Hoerth, C, Mozaffar, T, Rollins, YD, Nations, SP, Swenson, AJ, Shefner, JM, Andrews, JA & Koczon-Jaremko, BA 2014, 'ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, no. 3-4, pp. 192-203. https://doi.org/10.3109/21678421.2013.864312
Mitsumoto, Hiroshi ; Factor-Litvak, Pam ; Andrews, Howard ; Goetz, Raymond R. ; Andrews, Leslie ; Rabkin, Judith G. ; Mcelhiney, Martin ; Nieves, Jeri ; Santella, Regina M. ; Murphy, Jennifer ; Hupf, Jonathan ; Singleton, Jess ; Merle, David ; Kilty, Mary ; Heitzman, Daragh ; Bedlack, Richard S. ; Miller, Robert G. ; Katz, Jonathan S. ; Forshew, Dallas ; Barohn, Richard J. ; Sorenson, Eric J. ; Oskarsson, Bjorn ; Fernandes Filho, Jose Americo M ; Kasarskis, Edward J. ; Lomen-Hoerth, Catherine ; Mozaffar, Tahseen ; Rollins, Yvonne D. ; Nations, Sharon P. ; Swenson, Andrea J. ; Shefner, Jeremy M. ; Andrews, Jinsy A. ; Koczon-Jaremko, Boguslawa A. / ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS) : Study methodology, recruitment, and baseline demographic and disease characteristics. In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2014 ; Vol. 15, No. 3-4. pp. 192-203.
@article{2f09a96bed3345708f747e9c34d20c6a,
title = "ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics",
abstract = "In a multicenter study of newly diagnosed ALS patients without a reported family history of ALS, we are prospectively investigating whether markers of oxidative stress (OS) are associated with disease progression. Methods utilize an extensive structured telephone interview ascertaining environmental, lifestyle, dietary and psychological risk factors associated with OS. Detailed assessments were performed at baseline and at 3-6 month intervals during the ensuing 30 months. Our biorepository includes DNA, plasma, urine, and skin. Three hundred and fifty-five patients were recruited. Subjects were enrolled over a 36-month period at 16 sites. To meet the target number of subjects, the recruitment period was prolonged and additional sites were included. Results showed that demographic and disease characteristics were similar between 477 eligible/non-enrolled and enrolled patients, the only difference being type of health insurance among enrolled patients. Sites were divided into three groups by the number of enrolled subjects. Comparing these three groups, the Columbia site had fewer 'definite ALS' diagnoses. This is the first prospective, interdisciplinary, in-depth, multicenter epidemiological investigation of OS related to ALS progression and has been accomplished by an aggressive recruitment process. The baseline demographic and disease features of the study sample are now fully characterized.",
keywords = "ALS, Disease progression, Epidemiology, Oxidative stress, Survival",
author = "Hiroshi Mitsumoto and Pam Factor-Litvak and Howard Andrews and Goetz, {Raymond R.} and Leslie Andrews and Rabkin, {Judith G.} and Martin Mcelhiney and Jeri Nieves and Santella, {Regina M.} and Jennifer Murphy and Jonathan Hupf and Jess Singleton and David Merle and Mary Kilty and Daragh Heitzman and Bedlack, {Richard S.} and Miller, {Robert G.} and Katz, {Jonathan S.} and Dallas Forshew and Barohn, {Richard J.} and Sorenson, {Eric J.} and Bjorn Oskarsson and {Fernandes Filho}, {Jose Americo M} and Kasarskis, {Edward J.} and Catherine Lomen-Hoerth and Tahseen Mozaffar and Rollins, {Yvonne D.} and Nations, {Sharon P.} and Swenson, {Andrea J.} and Shefner, {Jeremy M.} and Andrews, {Jinsy A.} and Koczon-Jaremko, {Boguslawa A.}",
year = "2014",
month = "6",
doi = "10.3109/21678421.2013.864312",
language = "English (US)",
volume = "15",
pages = "192--203",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "3-4",

}

TY - JOUR

T1 - ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS)

T2 - Study methodology, recruitment, and baseline demographic and disease characteristics

AU - Mitsumoto, Hiroshi

AU - Factor-Litvak, Pam

AU - Andrews, Howard

AU - Goetz, Raymond R.

AU - Andrews, Leslie

AU - Rabkin, Judith G.

AU - Mcelhiney, Martin

AU - Nieves, Jeri

AU - Santella, Regina M.

AU - Murphy, Jennifer

AU - Hupf, Jonathan

AU - Singleton, Jess

AU - Merle, David

AU - Kilty, Mary

AU - Heitzman, Daragh

AU - Bedlack, Richard S.

AU - Miller, Robert G.

AU - Katz, Jonathan S.

AU - Forshew, Dallas

AU - Barohn, Richard J.

AU - Sorenson, Eric J.

AU - Oskarsson, Bjorn

AU - Fernandes Filho, Jose Americo M

AU - Kasarskis, Edward J.

AU - Lomen-Hoerth, Catherine

AU - Mozaffar, Tahseen

AU - Rollins, Yvonne D.

AU - Nations, Sharon P.

AU - Swenson, Andrea J.

AU - Shefner, Jeremy M.

AU - Andrews, Jinsy A.

AU - Koczon-Jaremko, Boguslawa A.

PY - 2014/6

Y1 - 2014/6

N2 - In a multicenter study of newly diagnosed ALS patients without a reported family history of ALS, we are prospectively investigating whether markers of oxidative stress (OS) are associated with disease progression. Methods utilize an extensive structured telephone interview ascertaining environmental, lifestyle, dietary and psychological risk factors associated with OS. Detailed assessments were performed at baseline and at 3-6 month intervals during the ensuing 30 months. Our biorepository includes DNA, plasma, urine, and skin. Three hundred and fifty-five patients were recruited. Subjects were enrolled over a 36-month period at 16 sites. To meet the target number of subjects, the recruitment period was prolonged and additional sites were included. Results showed that demographic and disease characteristics were similar between 477 eligible/non-enrolled and enrolled patients, the only difference being type of health insurance among enrolled patients. Sites were divided into three groups by the number of enrolled subjects. Comparing these three groups, the Columbia site had fewer 'definite ALS' diagnoses. This is the first prospective, interdisciplinary, in-depth, multicenter epidemiological investigation of OS related to ALS progression and has been accomplished by an aggressive recruitment process. The baseline demographic and disease features of the study sample are now fully characterized.

AB - In a multicenter study of newly diagnosed ALS patients without a reported family history of ALS, we are prospectively investigating whether markers of oxidative stress (OS) are associated with disease progression. Methods utilize an extensive structured telephone interview ascertaining environmental, lifestyle, dietary and psychological risk factors associated with OS. Detailed assessments were performed at baseline and at 3-6 month intervals during the ensuing 30 months. Our biorepository includes DNA, plasma, urine, and skin. Three hundred and fifty-five patients were recruited. Subjects were enrolled over a 36-month period at 16 sites. To meet the target number of subjects, the recruitment period was prolonged and additional sites were included. Results showed that demographic and disease characteristics were similar between 477 eligible/non-enrolled and enrolled patients, the only difference being type of health insurance among enrolled patients. Sites were divided into three groups by the number of enrolled subjects. Comparing these three groups, the Columbia site had fewer 'definite ALS' diagnoses. This is the first prospective, interdisciplinary, in-depth, multicenter epidemiological investigation of OS related to ALS progression and has been accomplished by an aggressive recruitment process. The baseline demographic and disease features of the study sample are now fully characterized.

KW - ALS

KW - Disease progression

KW - Epidemiology

KW - Oxidative stress

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84901494027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901494027&partnerID=8YFLogxK

U2 - 10.3109/21678421.2013.864312

DO - 10.3109/21678421.2013.864312

M3 - Article

C2 - 24564738

AN - SCOPUS:84901494027

VL - 15

SP - 192

EP - 203

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - 3-4

ER -